Evidence map›Paper›PMID 30401811›Full record

ArticleMolecular psychiatry2019

Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imaging.

Mandy Johnstone, Navneet A Vasistha, Miruna C Barbu, Owen Dando, Karen Burr, Edward Christopher, Sophie Glen, Christelle Robert, Rana Fetit, Kenneth G Macleod and 12 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Using Brain Organoids to Explore Human Neurobiology.Cellular and molecular neurobiology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in genetics · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Cellular Models in Schizophrenia Research.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
  18. Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Modeling neurological disorders using brain organoids.Seminars in cell & developmental biology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Mandy JohnstoneDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK. mandy.johnstone@ed.ac.uk.ORCID http://orcid.org/0000-0002-8398-0862
Navneet A VasisthaCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-6721-114X
Miruna C BarbuDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
Owen DandoUK Dementia Research Institute at University of Edinburgh, Edinburgh Medical School, Edinburgh, UK.ORCID http://orcid.org/0000-0002-6269-6408
Karen BurrCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Edward ChristopherCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-8569-618X
Sophie GlenDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
Christelle RobertRoyal (Dick) School of Veterinary Studies, The Roslin Institute, University of Edinburgh, Edinburgh, UK.
Rana FetitCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Kenneth G MacleodCancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Matthew R LiveseyCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
David St ClairInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK.
Douglas H R BlackwoodDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4076-9346
Kirsty MillarCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Neil O CarragherCancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Giles E HardinghamUK Dementia Research Institute at University of Edinburgh, Edinburgh Medical School, Edinburgh, UK.
David J A WyllieCentre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, 15 George Square, Edinburgh, UK.
Eve C JohnstoneDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
Heather C WhalleyDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4505-8869
Andrew M McIntoshDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-0198-4588
Stephen M LawrieDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2444-5675
Siddharthan ChandranCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. siddharthan.chandran@ed.ac.uk.

Funding

Chief Scientist Office SCD/12Medical Research Council G0902166Medical Research Council MR/J004367/1Medical Research Council MR/K026992/1Medical Research Council MR/N013255/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C011202/1Wellcome Trust 100135
6 · The paper itself

Abstract

The molecular basis of how chromosome 16p13.11 microduplication leads to major psychiatric disorders is unknown. Here we have undertaken brain imaging of patients carrying microduplications in chromosome 16p13.11 and unaffected family controls, in parallel with iPS cell-derived cerebral organoid studies of the same patients. Patient MRI revealed reduced cortical volume, and corresponding iPSC studies showed neural precursor cell (NPC) proliferation abnormalities and reduced organoid size, with the NPCs therein displaying altered planes of cell division. Transcriptomic analyses of NPCs uncovered a deficit in the NFκB p65 pathway, confirmed by proteomics. Moreover, both pharmacological and genetic correction of this deficit rescued the proliferation abnormality. Thus, chromosome 16p13.11 microduplication disturbs the normal programme of NPC proliferation to reduce cortical thickness due to a correctable deficit in the NFκB signalling pathway. This is the first study demonstrating a biologically relevant, potentially ameliorable, signalling pathway underlying chromosome 16p13.11 microduplication syndrome in patient-derived neuronal precursor cells.

Indexed as

Abnormalities, MultipleAdultAgedBrainCell ProliferationChromosome DuplicationChromosomes, Human, Pair 16FemaleHumansInduced Pluripotent Stem CellsIntellectual DisabilityMaleMental DisordersMiddle AgedNeuroimagingNeuronsNF-kappa B

Identifiers

PMID30401811
PMCPMC6344377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.